Institut Paoli Calmettes — Marseille

Public research footprint of Institut Paoli Calmettes, compiled from the ClinicalTrials.gov public registry.

747

Registered studies

313

Active

168

Recruiting now

308

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Triple-Negative Breast Cancer · Solid Tumor, Adult · HR Low-Positive/HER2-Negative Breast Neoplasms

Recently updated registry entries

NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)
NCT06919965 — A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… (Recruiting)
NCT04640623 — A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut Paoli Calmettes?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.